US Patent Issued to Antiva Biosciences on June 17 for "Compositions and dosage forms for treatment of HPV infection and HPV-induced neoplasia" (Chinese, American Inventors)

ALEXANDRIA, Va., June 19 -- United States Patent no. 12,329,768, issued on June 17, was assigned to Antiva Biosciences Inc. (Redwood City, Calif.).

"Compositions and dosage forms for treatment of HPV infection and HPV-induced neoplasia" was invented by Barry Aldous (Brisbane, Calif.), Ramakrishna Gadiraju (Brisbane, Calif.), Ankush Argade (Sunnyvale, Calif.), Zhengle Zhao (Shanghai), Siyi Jiang (Shanghai), Runyan Li (Shanghai), Chao Liu (Shanghai) and Minyan Liu (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "A pharmaceutically acceptable salt of an acyclic nucleotide phosphoramidate to treat HPV and related conditions including neoplasia, as well as pharmaceutical compositions, morphic forms and do...